UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

       Date of Report (Date of earliest event reported): November 27, 2007

                                   XsunX, Inc.
             (Exact name of registrant as specified in its charter)



   Colorado                          000-29621                84-1384159
  -----------                        ---------                ----------
(State or other jurisdiction   (Commission File Number)     (IRS Employer
of incorporation)                                           Identification No.)


                  65 Enterprise, Aliso Viejo, California 92656
                  --------------------------------------------
              (Address of principal executive offices and Zip Code)

        Registrant's telephone number, including area code (949) 330-8060


Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

|_| Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))

|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))





SECTION 1. Registrant's Business and Operations

Item 1.01 Entry into a Material Definitive Agreement

On November 26, 2007 the Company  authorized  an option grant to Dr.  Michael A.
Russak in  recognition of his acceptance to serve as a member of the XsunX Board
of  Directors.  The option  provides  for the grant of 500,000  options  with an
exercise  price  per  share  of  $0.36  for  Director  services  to be  rendered
commencing November 26, 2007. The vesting schedule is described below:

The vesting schedule for Dr. Russak is:

     The Option  shall  become  exercisable  in the  following  amounts upon the
     delivery and/or achievement by Optionee of the following milestones:

                (a)   Beginning  November  26,  2007 the  Option  shall vest and
                      become  exercisable  at the rate of 62,500 Shares upon the
                      anniversary of each calendar quarter of continuous service
                      as a Director,  or prorated portion thereof,  for services
                      rendered as a member of the Company  Board of Directors up
                      to a total of 500,000 shares.


SECTION 2.  Financial Information

None.

SECTION 3.  Securities and Trading Markets

None.

SECTION 4.  Matters Related to Accountants and Financial Statements

None.

SECTION 5.  Corporate Governance and Management

Item 5.02 Departure of  Directors or Principal Officers;  Election of Directors;
--------------------------------------------------------------------------------
Appointment of Principal Officers
---------------------------------

On November 28, 2007,  the Company  announced the  appointment of Dr. Michael A.
Russak as a Director,  effective  November 26, 2007. A copy of the related press
release is attached to this Current Report on Form 8-K as Exhibit 99.1.

Dr. Michael A. Russak's professional resume is as follows:

EDUCATION

Rutgers University, College of Engineering, B.S., Ceramic Engineering, 1968

Rutgers University,  College of Engineering,  Ph.D.,  Ceramic/Materials Science,
1971

PROFESSIONAL EXPERTISE:

Thirty five years industrial experience progressing from a research scientist to
senior executive officer.

Expertise  in  thin  film   materials   and  devices  for  magnetic   recording,
photovoltaic,  solar  thermal  applications,  semiconductor  devices  as well as
glass, glass-ceramic and ceramic materials.

Over  twelve  years  experience  at the  executive  management  level of  public
companies with significant off shore development and manufacturing functions.




PROFESSIONAL EXPERIENCE:

2007 - Present: Executive Director IDEMA-U.S. Responsibilities include oversight
of activities,  programs and trade shows  organized and sponsored by IDEMA,  the
International Disk (Drive) Equipment and Materials Association. IDEMA is the HDD
industry trade association.

2001-2006:  President and Chief Technical Officer, Komag, Inc.  Responsibilities
include  determining   overall  corporate  business  and  technical   direction,
extensive  interaction  with customer base and  investment  community,  led team
investigating  various  diversification  activities including single crystal and
thin film  photovoltaic  devices and thin film displays.  Between 2002 and 2006,
the Komag more than tripled its  production  output,  achieved  record  revenue,
profitability  and EPS.  Yearly  revenue  grew  from < $200M in 2001 to $900M in
2006.

1998  -  2001:  Executive  Vice  President  and  Chief  Technical  Officer,  HMT
Technology Corporation. Principal in the merger activities between HMT and Komag
in 2000. Merger completed in October 2000.  Responsible for technical  direction
of HMT and product transfer to manufacturing.

1993  -  1998:  Vice  President  of  Research  &  Development;   HMT  Technology
Corporation. Responsible for overall technical direction of company, research on
emerging  concepts  and  technologies  and new product and process  development.
Principal in the  management a leveraged  buy out and  subsequent  IPO of HMT in
1995-1996

1985 - 1993: IBM  Corporation;  various  positions  starting as a Research Staff
Member in the IBM TJ Watson Research Center,  Yorktown Heights,  NY and evolving
to a middle management position. Areas of management and individual contribution
included:

Materials  and  processes  related to high  density  magnetic  recording,  micro
magnetic modeling of soft magnetic materials.

Investigation of advanced plasma deposition and diagnostic  techniques including
low pressure sputter deposition, ion beam sputter deposition, ECR deposition and
etching and various plasma emission diagnostic techniques.

Application  of advanced  techniques to  semiconductor  devices for solar energy
conversion   (photovoltaic),   semiconductor  device  structures  and  packaging
applications.

1971-1985;  Grumman  Corporation,  Bethpage,  N.Y., Held positions of increasing
responsibilities  up to  rank of  Senior  Staff  Scientist  and  Senior  Program
Manager. Areas of management and individual contribution include:

Photovoltaic  materials,  devices and  applications;  Led a team of  scientists,
engineers and business  personnel in establishing a PV business base for Grumman
Energy Systems division of the company

Experience with photo electrochemical  devices, all solid state devices;  single
crystal  Si and GaAs as well as thin  film  amorphous  Si,  II-VI  compound  and
chalcogenide base devices.

Magnetic thin films for RAM and other applications.



High-Energy Laser countermeasures program.

Fundamental  research  into  melting  and  fining of glasses  and glass  ceramic
precursors in low gravity environment.

Thermal Protection Systems;  study,  characterization  and development of closed
pore insulation material for reusable heat shields for re-entry vehicles.

PATENTS & PUBLICATIONS: 23 Patents 90+ Publications

SECTION 6. Asset-Backed Securities

None

SECTION 7.  Regulation FD

Except for the historical  information  presented in this document,  the matters
discussed in this Form 8-K, or  otherwise  incorporated  by reference  into this
document,  contain "forward-looking  statements" (as such term is defined in the
Private  Securities  Litigation  Reform  Act  of  1995).  These  statements  are
identified  by the  use  of  forward-looking  terminology  such  as  "believes",
"plans", "intend", "scheduled",  "potential",  "continue", "estimates", "hopes",
"goal",  "objective",  expects", "may", "will", "should" or "anticipates" or the
negative thereof or other variations  thereon or comparable  terminology,  or by
discussions  of strategy that involve risks and  uncertainties.  The safe harbor
provisions  of Section 21E of the  Securities  Exchange Act of 1934, as amended,
and  Section  27A  of  the  Securities  Act  of  1933,  as  amended,   apply  to
forward-looking  statements made by the Registrant. The reader is cautioned that
no  statements  contained in this Form 8-K should be construed as a guarantee or
assurance of future  performance or results.  These  forward-looking  statements
involve risks and  uncertainties,  including those  identified  within this Form
8-K. The actual results that the Registrant  achieves may differ materially from
any  forward-looking  statements  due to such  risks  and  uncertainties.  These
forward-looking statements are based on current expectations, and the Registrant
assumes no obligation to update this information. Readers are urged to carefully
review and consider the various  disclosures made by the Registrant in this Form
8-K and in the Registrant's other reports filed with the Securities and Exchange
Commission  that attempt to advise  interested  parties of the risks and factors
that may affect the Registrant's business.

Note:  Information  in this  report  furnished  pursuant  to Item 7 shall not be
deemed to be "filed" for purposes of Section 18 of the  Securities  Exchange Act
of 1934, as amended,  or otherwise  subject to the  liabilities of that section.
The  information in this current report shall not be  incorporated  by reference
into any  registration  statement  pursuant to the  Securities  Act of 1933,  as
amended.  The  furnishing  of the  information  in this  current  report  is not
intended to, and does not,  constitute a representation  that such furnishing is
required by Regulation FD or that the  information  this current report contains
is material investor information that is not otherwise publicly available.

On  November  28,  2007,  XsunX  Inc.  issued a news  release  to  announce  the
appointment of Dr. Michael A. Russak to the Company's  Board of Directors.  This
news release,  dated  November 28, 2007 is attached as Exhibit 99.1 to this Form
8-K and is incorporated herein by reference.

SECTION 8.  Other Events

None.

SECTION 9.  Financial Statements and Exhibits

Item 9.01  Financial Statements and Exhibits

The following exhibit is furnished as part of this report:


        A.  Financial Statements - none

        B.  Exhibit -  10.1 Stock Option Agreement (Dr. Russak)

        C.  Exhibit -  99.1 Press release dated November 28, 2007



                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

Date: November 28, 2007

                                   XSUNX, INC.



                                   By: /s/ Tom Djokovich
                                       -----------------------------
                                       Tom Djokovich, CEO & President